Access Site Related Vascular Complications following Percutaneous Cardiovascular Procedures
Vascular access site complications (ASC) are among the most frequent complications of percutaneous cardiovascular procedures (PCP) and are associated with adverse outcome and high resources utilization. In this prospective study, we investigated patients with postprocedural clinical suspicion of ASC...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6a852db884c84db5b7ec0d0e7034e39f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6a852db884c84db5b7ec0d0e7034e39f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6a852db884c84db5b7ec0d0e7034e39f2021-11-25T18:00:12ZAccess Site Related Vascular Complications following Percutaneous Cardiovascular Procedures10.3390/jcdd81101362308-3425https://doaj.org/article/6a852db884c84db5b7ec0d0e7034e39f2021-10-01T00:00:00Zhttps://www.mdpi.com/2308-3425/8/11/136https://doaj.org/toc/2308-3425Vascular access site complications (ASC) are among the most frequent complications of percutaneous cardiovascular procedures (PCP) and are associated with adverse outcome and high resources utilization. In this prospective study, we investigated patients with postprocedural clinical suspicion of ASC evaluated by duplex ultrasound (DUS) for the presence of ASC. We assessed the incidence, in-hospital outcome, treatment of complications and predictors for ASC. Overall, 12,901 patients underwent PCP during a 40 months period. Of those, 2890 (22.4%) patients had postprocedural clinical symptoms of ASC and were evaluated using DUS. An ASC was found in 206 of the DUS examined patients (corresponding to 7.1% of the 2890 DUS examined patients). In 6.7% of all valvular/TAVI procedures, an ASC was documented, while coronary, electrophysiological and peripheral PCP had a comparable and low rate of complications (1.2–1.5%). Pseudoaneurysm (PSA) was the most frequent ASC (67.5%), followed by arteriovenous fistula (13.1%), hematoma (7.8%) and others (11.7%). Of all PSA, 84 (60.4%) were treated surgically, 44 (31.6%) by manual compression and 11 (7.9%) conservatively. Three (0.02%) patients died due to hemorrhagic shock. In conclusion, femoral ASC are rare in the current era of PCP with PSA being the leading type of ASC. Nonetheless, patients with predisposing risk factors and postprocedural suspicious clinical findings should undergo a DUS to early detect and mitigate ASC-associated outcome.Johanna HetrodtChristiane EngelbertzKatrin GebauerJacqueline StellaMatthias MeyborgEva FreisingerHolger ReineckeNasser MalyarMDPI AGarticlepercutaneous cardiovascular proceduresaccess site complicationsfemoral accesspseudoaneurysmoutcomeDiseases of the circulatory (Cardiovascular) systemRC666-701ENJournal of Cardiovascular Development and Disease, Vol 8, Iss 136, p 136 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
percutaneous cardiovascular procedures access site complications femoral access pseudoaneurysm outcome Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
percutaneous cardiovascular procedures access site complications femoral access pseudoaneurysm outcome Diseases of the circulatory (Cardiovascular) system RC666-701 Johanna Hetrodt Christiane Engelbertz Katrin Gebauer Jacqueline Stella Matthias Meyborg Eva Freisinger Holger Reinecke Nasser Malyar Access Site Related Vascular Complications following Percutaneous Cardiovascular Procedures |
description |
Vascular access site complications (ASC) are among the most frequent complications of percutaneous cardiovascular procedures (PCP) and are associated with adverse outcome and high resources utilization. In this prospective study, we investigated patients with postprocedural clinical suspicion of ASC evaluated by duplex ultrasound (DUS) for the presence of ASC. We assessed the incidence, in-hospital outcome, treatment of complications and predictors for ASC. Overall, 12,901 patients underwent PCP during a 40 months period. Of those, 2890 (22.4%) patients had postprocedural clinical symptoms of ASC and were evaluated using DUS. An ASC was found in 206 of the DUS examined patients (corresponding to 7.1% of the 2890 DUS examined patients). In 6.7% of all valvular/TAVI procedures, an ASC was documented, while coronary, electrophysiological and peripheral PCP had a comparable and low rate of complications (1.2–1.5%). Pseudoaneurysm (PSA) was the most frequent ASC (67.5%), followed by arteriovenous fistula (13.1%), hematoma (7.8%) and others (11.7%). Of all PSA, 84 (60.4%) were treated surgically, 44 (31.6%) by manual compression and 11 (7.9%) conservatively. Three (0.02%) patients died due to hemorrhagic shock. In conclusion, femoral ASC are rare in the current era of PCP with PSA being the leading type of ASC. Nonetheless, patients with predisposing risk factors and postprocedural suspicious clinical findings should undergo a DUS to early detect and mitigate ASC-associated outcome. |
format |
article |
author |
Johanna Hetrodt Christiane Engelbertz Katrin Gebauer Jacqueline Stella Matthias Meyborg Eva Freisinger Holger Reinecke Nasser Malyar |
author_facet |
Johanna Hetrodt Christiane Engelbertz Katrin Gebauer Jacqueline Stella Matthias Meyborg Eva Freisinger Holger Reinecke Nasser Malyar |
author_sort |
Johanna Hetrodt |
title |
Access Site Related Vascular Complications following Percutaneous Cardiovascular Procedures |
title_short |
Access Site Related Vascular Complications following Percutaneous Cardiovascular Procedures |
title_full |
Access Site Related Vascular Complications following Percutaneous Cardiovascular Procedures |
title_fullStr |
Access Site Related Vascular Complications following Percutaneous Cardiovascular Procedures |
title_full_unstemmed |
Access Site Related Vascular Complications following Percutaneous Cardiovascular Procedures |
title_sort |
access site related vascular complications following percutaneous cardiovascular procedures |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/6a852db884c84db5b7ec0d0e7034e39f |
work_keys_str_mv |
AT johannahetrodt accesssiterelatedvascularcomplicationsfollowingpercutaneouscardiovascularprocedures AT christianeengelbertz accesssiterelatedvascularcomplicationsfollowingpercutaneouscardiovascularprocedures AT katringebauer accesssiterelatedvascularcomplicationsfollowingpercutaneouscardiovascularprocedures AT jacquelinestella accesssiterelatedvascularcomplicationsfollowingpercutaneouscardiovascularprocedures AT matthiasmeyborg accesssiterelatedvascularcomplicationsfollowingpercutaneouscardiovascularprocedures AT evafreisinger accesssiterelatedvascularcomplicationsfollowingpercutaneouscardiovascularprocedures AT holgerreinecke accesssiterelatedvascularcomplicationsfollowingpercutaneouscardiovascularprocedures AT nassermalyar accesssiterelatedvascularcomplicationsfollowingpercutaneouscardiovascularprocedures |
_version_ |
1718411747942989824 |